248 related articles for article (PubMed ID: 18578610)
21. Metastases to the thyroid gland: seventeen cases operated on in a single clinical center.
Cichoń S; Anielski R; Konturek A; Barczyński M; Cichoń W
Langenbecks Arch Surg; 2006 Nov; 391(6):581-7. PubMed ID: 16983577
[TBL] [Abstract][Full Text] [Related]
22. Metastasis of renal cell carcinoma to the thyroid gland 19 years after nephrectomy: a case report.
Kihara M; Yokomise H; Yamauchi A
Auris Nasus Larynx; 2004 Mar; 31(1):95-100. PubMed ID: 15041062
[TBL] [Abstract][Full Text] [Related]
23. Metastatic thyroid carcinoma.
Kaya H; Barbaros U; Erbil Y; Bozbora A; Kapran Y; Aral F; Ozarmağan S
N Z Med J; 2005 Oct; 118(1224):U1705. PubMed ID: 16258580
[TBL] [Abstract][Full Text] [Related]
24. Granulomatous reaction within the thyroid metastases of a renal cell carcinoma.
D'Angelo FA; Magistri P; Antolino L; Socciarelli F
Int J Surg Pathol; 2014 Feb; 22(1):87-9. PubMed ID: 23775018
[TBL] [Abstract][Full Text] [Related]
25. Thyroid metastasis from renal cell carcinoma eight years after radical nephrectomy: a case report.
Uzel C; Coşkun H; Terzioğlu T; Aras N
Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):152-6. PubMed ID: 15542944
[TBL] [Abstract][Full Text] [Related]
26. Late onset metastases to the thyroid gland from renal carcinoma.
Villumsen AL; Mevik K; Fjøsne HE; Brekke MB; Haugen OA
Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2262-5. PubMed ID: 24226333
[TBL] [Abstract][Full Text] [Related]
27. Survival data justifies resection for pancreatic metastases.
Strobel O; Hackert T; Hartwig W; Bergmann F; Hinz U; Wente MN; Fritz S; Schneider L; Büchler MW; Werner J
Ann Surg Oncol; 2009 Dec; 16(12):3340-9. PubMed ID: 19777190
[TBL] [Abstract][Full Text] [Related]
28. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
29. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
30. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
31. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
34. [Management of pancreatic metastases from renal cell carcinoma report of five cases].
Köhler K; Haroske G; Ludwig K
Zentralbl Chir; 2006 Oct; 131(5):425-8. PubMed ID: 17089295
[TBL] [Abstract][Full Text] [Related]
35. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
[TBL] [Abstract][Full Text] [Related]
36. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
37. Impact of Microvascular Invasion and Tumor Necrosis on the Prognosis of Korean Patients with pT1b Renal Cell Carcinoma.
Kwon SY; Lee JN; Kim BS; Ko YH; Song PH; Kim HT; Kim TH; Yoo ES; Choi GS; Kim BW; Kwon TG
Urol Int; 2015; 95(1):65-71. PubMed ID: 25413438
[TBL] [Abstract][Full Text] [Related]
38. [Isolated thyroid and skin metastases of renal carcinoma].
Congiu A; Nicolosi A; Malloci A; Piga A; Calò PG; Murtas MG
Minerva Chir; 1994 Mar; 49(3):223-7. PubMed ID: 8028737
[TBL] [Abstract][Full Text] [Related]
39. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
